Announcements Trials
Browse Landscape

Phase

Phase 1/2 1Phase 1 1

Status

Completed 2

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 1

Conditions

Neovascularization, Pathologic 2Lung Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

pembrolizumab 1033Carboplatin 971Paclitaxel 942Gemcitabine 799Cisplatin 757Docetaxel 698Bevacizumab 637Nivolumab 520Pemetrexed 507Capecitabine 475Cyclophosphamide 473Fluorouracil 425Dexamethasone 410Rituximab 391Oxaliplatin 352Injections 347Trastuzumab 314atezolizumab 312Cetuximab 291Leucovorin 290Irinotecan 271130-nm albumin-bound paclitaxel 257Prednisone 251Ipilimumab 244Doxorubicin 241Lenalidomide 231Fulvestrant 226fludarabine 219durvalumab 211Erlotinib Hydrochloride 196

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
INDUSTRY × S 3304 × Clear all
NCT00078390 2018-05-02

Study of S-3304 in Patients With Locally Advanced Non-Small Cell Lung Cancer

Shionogi Inc.

Phase 1/2 Completed
9 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neovascularization, Pathologic

NCT00033215 2018-04-26

A Phase 1 Study of S-3304 in Patients With Solid Tumors

Shionogi Inc.

Phase 1 Completed
32 enrolled

Neovascularization, Pathologic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡